BEDFORD, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced today that Katrine Bosley, Avila’s CEO, is scheduled to present at the Lazard Capital Markets 8th Annual Healthcare Conference at 8:30 a.m. ET on Monday, November 15, 2011, at the Pierre Hotel, New York.
